This discrepancy isn't shared with other dopamine reuptake inhbitors like bupropion, sibutramine, mazindol or tesofensine, which have very similar or greater potencies than copyright as dopamine reuptake inhibitors. These results have evoked a speculation that copyright could also operate to be a so-referred to as "DAT inverse agonist" or "detrimen